Webinar on-demand: Lessons for the Commercial Supply Chain Taken From the Clinical Trials Model

By Christopher Engel |

Today's commercial drug supply chain has key-drivers that require a re-design of the current logistics model. From specialty to orphan drugs the market is expecting exponential growth compared to traditional drugs, which in turn presents shipping challenges. Varying patient and logistics requirements, international pharmaceutical regulation compliance and the increasing number of approved biologic and high value, low volume products all combine to ensure that the efficient and safe distribution of medication to patients can be a complex task.

Due to this change of paradigm in the logistics of pharmaceutical throughout the last years there is no more one-size-fits all approach but a rising need to switch to more tailor-made logistics solutions.

This webinar addresses how to deliver best practices and learning from a specialty courier point of view, providing participants with insights on the logistics of multi-centric clinical trials around the globe. Christopher Engel also discusses how this knowledge can be transferred and applied to the logistics of commercialized specialty drugs with complex shipping requirements.


About the Author

A portrait of Christopher Engel.

Christopher Engel

Senior Manager, Global Commercial Supply Chain
World Courier
View Bio